文献速递慢阻肺

HDAC2通过抑制IL-17A介导的气道重塑在慢阻肺中的作用

HDAC2 Suppresses IL17A-Mediated Airway Remodeling in Human and Experimental Modeling of COPD.
PubMed 文献 · Chest · 2017-11-04

本研究探讨组蛋白去乙酰化酶2(HDAC2)是否通过IL-17A依赖机制抑制香烟烟雾诱导的气道重塑。利用慢阻肺患者痰液和肺组织、CS诱导的小鼠模型及体外细胞实验,发现HDAC2与IL-17A表达与支气管壁增厚和胶原沉积相关。Il-17a缺陷减轻而Hdac2缺陷加重CS诱导的小鼠气道重塑,IL-17A缺失也减轻Hdac2+/-小鼠的气道重塑。结论提示激活HDAC2和/或抑制IL-17A可能预防慢阻肺气道重塑。

要点

  • HDAC2和IL-17A表达与慢阻肺患者支气管壁增厚和胶原沉积相关。
  • IL-17A缺陷减轻而HDAC2缺陷加重香烟烟雾诱导的小鼠气道重塑。
  • IL-17A通过自分泌TGF-β1部分介导人成纤维细胞活化。

核心结论

  • 激活HDAC2和/或抑制IL-17A产生可能通过抑制气道炎症和调节成纤维细胞活化来预防慢阻肺气道重塑。

研究设计与样本

  • 研究纳入对照组和慢阻肺患者的痰液及肺组织标本,并采用香烟烟雾诱导的慢阻肺小鼠模型及人支气管上皮细胞和原代人成纤维细胞的体外培养。

主要发现

  • 慢阻肺患者痰细胞和肺组织中HDAC2与IL-17A表达与支气管壁增厚和胶原沉积相关。
  • Il-17a缺陷减轻而Hdac2缺陷加重香烟烟雾诱导的小鼠气道重塑,IL-17A缺失也减轻CS暴露的Hdac2+/-小鼠气道重塑。
  • HDAC2部分通过调节CD4+ T细胞在Th17分化及气道上皮细胞RORγt调控IL-17A产生。
  • 体外IL-17A缺陷减轻CS诱导的Hdac2+/-小鼠成纤维细胞活化,IL-17A诱导的人成纤维细胞活化至少部分由自分泌TGF-β1介导。

临床怎么用

  • HDAC2激活和/或IL-17A抑制可能成为预防慢阻肺气道重塑的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although airway remodeling is a central feature of COPD, the mechanisms underlying its development have not been fully elucidated. The goal of this study was to determine whether histone deacetylase (HDAC) 2 protects against cigarette smoke (CS)-induced airway remodeling through IL-17A-dependent mechanisms. METHODS: Sputum samples and lung tissue specimens were obtained from control subjects and patients with COPD. The relationships between HDAC2, IL-17A, and airway remodeling were investigated. The effect of HDAC2 on IL-17A-mediated airway remodeling was assessed by using in vivo models of COPD induced by CS and in vitro culture of human bronchial epithelial cells and primary human fibroblasts exposed to CS extract, IL-17A, or both. RESULTS: HDAC2 and IL-17A expression in the sputum cells and lung tissue samples of patients with COPD were associated with bronchial wall thickening and collagen deposition. Il-17a deficiency (Il-17a-/-) resulted in attenuation of, whereas Hdac2 deficiency (Hdac2+/-) exacerbated, CS-induced airway remodeling in mice. IL-17A deletion also attenuated airway remodeling in CS-exposed Hdac2+/- mice. HDAC2 regulated IL-17A production partially through modulation of CD4+ T cells during T helper 17 cell differentiation and retinoid-related orphan nuclear receptor γt in airway epithelial cells. In vitro, IL-17A deficiency attenuated CS-induced mouse fibroblast activation from Hdac2+/- mice. IL-17A-induced primary human fibroblast activation was at least partially mediated by autocrine production of transforming growth factor beta 1. CONCLUSIONS: These findings suggest that activation of HDAC2 and/or inhibition of IL-17A production could prevent the development of airway remodeling by suppressing airway inflammation and modulating fibroblast activation in COPD.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Lai T, Tian B, Cao C, et al. HDAC2 Suppresses IL17A-Mediated Airway Remodeling in Human and Experimental Modeling of COPD. Chest. 2017. PMID: 29113816. doi:10.1016/j.chest.2017.10.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。